← Insider buys
RVNC

Revance Therapeutics, Inc.

SVP, General Counsel and Secretary Dwight Moxie sold $584K of Revance Therapeutics, Inc.

Sold$584,220
$31.59Price
18,496Shares
−25%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Thu, Mar 9. Filed Thu, Mar 9, 4:46 PM ET, after the close. Not investment advice.